Ovarian Cancer and Us - best viewed in FIREFOX

Search: this blog, links from posts and the web.....

Loading...

Tuesday, February 22, 2011

When the Doctor's Wife Has Breast Cancer - NYTimes.com




Abstract: Persistent Noncompliance With the Work-Hour Regulation (patient safety)



Note:
the Transportation Industry has been dealing with 'hours of service'
issues for decades    (same issues/different industry - fatigue)


 NOTE: A new Hours-of-Service (HOS) Proposed Rulemaking was published
on December 29, 2010. For details, visit the HOS Proposed Rule page to view the complete rulemaking, summary of changes, FAQs, and other related information.

Health-related quality of life and cancer clinical trials — Therapeutic Advances in Medical Oncology



"...Health-related quality of life has become a more accurate predictor of survival than some other clinical parameters, such as performance status. The overall outlook for the routine assessment of patient-reported outcomes in clinical trials is assured and, eventually, it is likely to become a standard part of clinical practice. ...."

Feb 21st, 2011: Ovarian cancer - Cancer Network (worth reading/overview of ovarian cancer)



Note: good overview of ovarian cancer biology, treatments, genetics, diet, environment, hormonal factors...

By Stephen C. Rubin, MD, Paul Sabbatini, MD, and Akila N. Viswanathan, MD, MPH | February 21, 2011

Expert Perspectives in Oncology: Contemporary Approaches in Targeting Angiogenesis prIME Oncology



Note: requires registration to view (free), also speaks about ICON 7 (ovarian cancer/avastin trial) Module Six Practical Considerations in Patient Management Involving Antiangiogenic Therapy

St. Gallen Satellite Symposium titled,: “‘Perplexing Questions in Early Breast Cancer: Answers from the Experts | prIME Oncology



Note: requires registration to view (free)

Meeting Overview

We are pleased to invite you to our St Gallen Satellite Symposium titled, “Perplexing Questions in Early Breast Cancer: Answers from the Experts," to be held on 17 March 2011 in St Gallen, Switzerland.

During this interactive meeting, leaders in the field will discuss clinical issues in the field of early breast cancer.